| Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis A Haghikia, T Hegelmaier, D Wolleschak, M Böttcher, V Pappa, J Motte, ... Annals of the Rheumatic Diseases, 2024 | | 2024 |
| Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome S Faissner, J Motte, M Sgodzai, C Geis, A Haghikia, D Mougiakakos, ... Proceedings of the National Academy of Sciences 121 (26), e2403227121, 2024 | | 2024 |
| Neuroaxonal damage in natalizumab-treated MS patients: The role of JCV antibody titres G Dalla Costa, L Leocani, M Pisa, T Croese, V Martinelli, L Moiola, ... Multiple Sclerosis Journal, 13524585241260977, 2024 | | 2024 |
| OP0029 GUT-SPECIFIC H3R SIGNALING ORCHESTRATES MICROGLIA-DEPENDENT RESOLUTION OF PERIPHERAL INFLAMMATION K Dürholz, M Linnerbauer, E Schmid, H Danzer, V Azizov, S Lucas, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 50-51, 2024 | | 2024 |
| B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases A Haghikia, G Schett, D Mougiakakos The Lancet Neurology 23 (6), 615-624, 2024 | | 2024 |
| Pneumonia induced rise in glucagon promotes endothelial damage and vascular thrombogenicity PR Rad, V Nageswaran, L Peters, L Reinshagen, J Roessler, S Simmons, ... | | 2024 |
| Propionic acid promotes neurite recovery in damaged multiple sclerosis neurons B Gisevius, A Duscha, G Poschmann, K Stühler, J Motte, AL Fisse, ... Brain Communications 6 (3), 2024 | | 2024 |
| Treatment of concomitant myasthenia gravis and Lambert-Eaton myasthenic syndrome with autologous CD19-targeted CAR T cells J Motte, M Sgodzai, C Schneider-Gold, N Steckel, T Mika, T Hegelmaier, ... Neuron, 2024 | 1 | 2024 |
| Successful Treatment of Concomitant Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome with Autologous CD19-targeted CAR-T Cells (P4-14.006) J Motte, M Sgodzai, C Schneider-Gold, D Borie, T Hegelmaier, A Haghikia, ... Neurology 102 (17_supplement_1), 6515, 2024 | | 2024 |
| Supporting immunomodulatory agent R Gold, A Haghikia, R Linker US Patent 11,865,091, 2024 | | 2024 |
| Predictors for Adherence to Recommended Anticoagulation after Stroke Unit Discharge in Patients with Atrial Fibrillation T Frank, J Neumann, A Assmann, S Schreiber, A Haghikia, M Barleben, ... Cerebrovascular Diseases Extra 14 (1), 21-29, 2024 | | 2024 |
| Sensory nerve conduction studies in infants, children and teenagers–An update T Frenzel, AK Baum, H Krause, C Arens, A Haghikia, I Galazky Clinical Neurophysiology Practice 9, 63-68, 2024 | | 2024 |
| Medical graphics to improve patient understanding and anxiety in elderly and cognitively impaired patients scheduled for transcatheter aortic valve implantation (TAVI) A Brand, C Hornig, C Crayen, A Hamann, S Martineck, DM Leistner, ... Clinical Research in Cardiology, 1-11, 2023 | 1 | 2023 |
| Anti-CD19 CAR T cells for refractory myasthenia gravis A Haghikia, T Hegelmaier, D Wolleschak, M Böttcher, C Desel, D Borie, ... The Lancet Neurology 22 (12), 1104-1105, 2023 | 22 | 2023 |
| Supplementation with short-chain fatty acids and the prebiotic 2FL improves clinical outcome in PD T Hegelmaier, A Duscha, C Desel, S Fuchs, M Shapira, Q Shan, GI Stangl, ... medRxiv, 2023.11. 01.23297866, 2023 | | 2023 |
| Study protocol: value of 7-T MRI with prospective motion correction and postprocessing for patients with nonlesional epilepsy O Kukhlenko, R Kukhlenko, C Tempelmann, O Speck, H Hinrichs, ... Clinical Epileptology 36 (4), 320-326, 2023 | | 2023 |
| Attenuation of rapid inflammasome activation in post-myocardial infarction monocytes is potentially mediated by TNFAIP3 H Giral, V Franke, M Moobed, J Hartung, N Kraenkel, C Seppelt, ... European Heart Journal 44 (Supplement_2), ehad655. 3213, 2023 | | 2023 |
| Patient-reported functional and symptomatic outcomes in patients with mild cognitive disorder undergoing transcatheter aortic valve implantation-A secondary analysis of a … T Thevathasan, C Hornig, DM Leistner, S Suendermann, A Unbehaun, ... European Heart Journal 44 (Supplement_2), ehad655. 1718, 2023 | | 2023 |
| Progesterone Receptor Membrane Component 1 (PGRMC1) Modulates Tumour Progression, the Immune Microenvironment and the Response to Therapy in Glioblastoma CA Dumitru, H Schröder, FTA Schäfer, JF Aust, N Kreße, CLR Siebert, ... Cells 12 (20), 2498, 2023 | 5 | 2023 |
| Culprit plaque morphology determines inflammatory risk and clinical outcomes in acute coronary syndrome T Gerhardt, C Seppelt, YS Abdelwahed, D Meteva, C Wolfram, ... European heart journal 44 (38), 3911-3925, 2023 | 15 | 2023 |
